TIOMA THERAPEUTICS, INC.

Profile

Company Names

TIOMA THERAPEUTICS, INC.
VASCULOX, INC.

Addresses

2000 SIERRA POINT PARKWAY, SUITE 700, BRISBANE, CA 94005

4320 FOREST PARK AVE., SUITE 304, SAINT LOUIS, MO 63108

Phone Numbers

4156714024
860-938-2315

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$34,446,298.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2015-06-25 
$33,176,948.00 
$86,253,438.00 
$53,076,490.00 
Equity 
1
2014-12-18 
$1,269,350.00 
$2,768,250.00 
$1,498,900.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KALTHLEEN 
L. 
BECKMANN 
EXECUTIVE OFFICER
VASCULOX, INC.
KATHLEEN 
L. 
BECKMANN 
EXECUTIVE OFFICER
VASCULOX, INC.
CHARLES 
 
BOLTEN 
DIRECTOR
CONFLUENCE LIFE SCIENCES, INC.   |  EUCLISES PHARMACEUTICALS, INC.   |  PROSTATE MANAGEMENT DIAGNOSTICS INC.   |  VASCULOX, INC.   |  MEDIBEACON LLC   |  ANTEGRIN THERAPEUTICS, INC.   |  NANOPORE DIAGNOSTICS, LLC   |  CANOPY BIOSCIENCES, LLC   |  ELIRA, INC.   |  SENTIAR, INC.   |  COVERCRESS INC.   |  PLASTOMICS INC.   |  IMPETUS AGRICULTURE, INC.   |  SOLIS AGROSCIENCES INC.
DAN 
 
BRODERICK 
DIRECTOR
NAWGAN PRODUCTS, LLC   |  CONFLUENCE LIFE SCIENCES, INC.   |  BENSON HILL BIOSYSTEMS, INC.   |  CASSIDY TURLEY, INC.   |  VASCULOX, INC.   |  GENERICO, LLC   |  EDISON AGROSCIENCES, INC.   |  HEALTHY BYTES, INC.   |  AHC REAL ESTATE FUND X, LP
GEORGE 
 
CAPPS 
EXECUTIVE OFFICER
VASCULOX, INC.
JILL 
 
CARROLL 
DIRECTOR
VASCULOX, INC.   |  TIOMA THERAPEUTICS, INC.   |  ARCELLX, INC.   |  NKARTA, INC.   |  PANDION THERAPEUTICS HOLDCO LLC   |  ODYSSEY THERAPEUTICS, INC.   |  AVALYN PHARMA INC.   |  AIRNEXIS THERAPEUTICS, INC.
JOHN 
 
DONOVAN 
EXECUTIVE OFFICER, DIRECTOR
LENDINGCLUB CORP   |  RENAVANCE PHARMA, INC.   |  ALIOS BIOPHARMA INC   |  TIOMA THERAPEUTICS, INC.   |  CONCENTRIC ANALGESICS, INC.   |  OLEA NETWORKS, INC.   |  TOLERION, INC.   |  LUCATA CORP   |  NOVASIGNAL CORP.   |  CRESTA INTELLIGENCE INC.   |  HUNTINGTON FERMI FUSION, LLC
WILLIAM 
 
FRAZIER 
DIRECTOR
VASCULOX, INC.   |  VIEMED HEALTHCARE, INC.
ROBERT 
W. 
KARR 
EXECUTIVE OFFICER, DIRECTOR
TERPENOID THERAPEUTICS, INC.   |  EUCLISES PHARMACEUTICALS, INC.   |  VASCULOX, INC.   |  ANTEGRIN THERAPEUTICS, INC.   |  TIOMA THERAPEUTICS, INC.
PAMELA 
 
MANNING 
EXECUTIVE OFFICER
VASCULOX, INC.
PAMELA 
T. 
MANNING 
EXECUTIVE OFFICER
TIOMA THERAPEUTICS, INC.
JOHN 
 
MCKEARN 
DIRECTOR
OTONOMY, INC.   |  LUMENA PHARMACEUTICALS, INC.   |  ZS PHARMA, INC.   |  ALLAKOS INC.   |  VASCULOX, INC.   |  TIOMA THERAPEUTICS, INC.   |  ONCORESPONSE INC   |  GOOD THERAPEUTICS, INC.   |  ADARZA BIOSYSTEMS, INC.   |  BONUM THERAPEUTICS, INC.   |  ONCORESPONSE, INC
PETER 
 
MOLDT 
DIRECTOR
CARDEAS PHARMA CORP   |  ALLAKOS INC.   |  BIOCLIN THERAPEUTICS, INC.   |  CORVUS PHARMACEUTICALS, INC.   |  VASCULOX, INC.   |  E-SCAPE BIO, INC.   |  TIOMA THERAPEUTICS, INC.   |  BOLT BIOTHERAPEUTICS, INC.   |  VIEWPOINT THERAPEUTICS, INC.   |  OUTPOST MEDICINE, LLC   |  SWIFT HEALTH SYSTEMS INC.   |  ALIGOS THERAPEUTICS, INC.   |  ESCAPE BIO, INC.   |  AVALYN PHARMA INC.
CAROLE 
L. 
NUECHTERLEIN 
DIRECTOR
TIOMA THERAPEUTICS, INC.
BOBBY 
W. 
SANDAGE, JR. 
DIRECTOR
OSTEOLOGIX, INC.   |  VASCULOX, INC.   |  EUCLISES PHARMACEUTICALS, INC.   |  MATEON THERAPEUTICS INC   |  GENEOSCOPY, INC.
JAMES 
 
STUTZ 
EXECUTIVE OFFICER
TIOMA THERAPEUTICS, INC.   |  TOLERION, INC.   |  NEURONA THERAPEUTICS, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-08-17
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-25 
2015-08-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-25 
2015-02-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-12-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#